This review will focus on the general approach to, and treatment of, thrombocytopenia in cancer patients, including thrombopoietin treatment in patients receiving non-myeloablative chemotherapy.
David J. Kuter, MD, DPhil
Advertisement
Articles by David J. Kuter, MD, DPhil
Advertisement
Latest Updated Articles
Managing Thrombocytopenia Associated With Cancer ChemotherapyPublished: April 15th 2015 | Updated:
Advertisement
Advertisement
Trending on CancerNetwork
1
FDA Approves Lurbinectedin/Atezolizumab Maintenance in ES-SCLC
2
Which Therapy Has the Best Efficacy in Transplant-Ineligible NDMM?
3
Companion Diagnostic Earns FDA Approval for Imlunestrant in Breast Cancer
4
Tarlatamab May Offer New SOC for Relapsed ES-SCLC With Brain Metastases
5
